Evrenzo® (roxadustat) Tablets Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients

Corporate Breaking News

Home : Evrenzo® (roxadustat) Tablets Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients

Sep 20 2019	Evrenzo® (roxadustat) Tablets Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
TOKYO and SAN FRANCISCO, Sept. 20, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and FibroGen, Inc. (Nasdaq: FGEN, Interim CEO: James A Schoeneck., "FibroGen") today announced that Japan's Ministry of Health, Labour and Welfare...


Source:https://www.prnewswire.com:443/news-releases/evrenzo-roxadustat-tablets-approved-in-japan-for-the-treatment-of-anemia-associated-with-chronic-kidney-disease-in-dialysis-patients-300922278.html

Related News
» Grand Opening of the Main Building of the Daimaru Shinsaibashi Store, a Flagship Store that Promotes ESG Initiatives Committed to Contributing to a Low-Carbon Society Using 100% Renewable Energy for In-House Electric Power » 1 killed, 7 injured after tour bus crashes off California highway